SCHEMBL22552432

SCHEMBL22552432

CCCCCCC[C@@H](O)[C@@H](CC)C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.59
FFAR1 O14842 2/20 0.59
MAPT P10636 2/20 0.52
LCK P06239 1/20 0.52
PPARD Q03181 1/20 0.52
ZDHHC20 Q5W0Z9 1/20 0.52
ZDHHC2 Q9UIJ5 1/20 0.52
FFAR4 Q5NUL3 1/20 0.48
ACE2 Q9BYF1 1/20 0.48
SPHK1 Q9NYA1 2/20 0.48
CYP2D6 P10635 2/20 0.46
GMNN O75496 1/20 0.46
LMNA P02545 1/20 0.46
POLB P06746 1/20 0.46
THPO P40225 1/20 0.46
MTOR P42345 1/20 0.46
BLM P54132 1/20 0.46
KDM4E B2RXH2 1/20 0.46
TP53 P04637 1/20 0.46
CYP1A2 P05177 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21550303 1.00 GPR84 (0.59) GPR84FFAR1MAPTLCKPPARD
SCHEMBL20820018 1.00 GPR84 (0.59) GPR84FFAR1MAPTLCKPPARD
SCHEMBL5165089 0.98 GPR84 (0.55) GPR84FFAR1MAPTLCKPPARD
SCHEMBL27570202 0.92 CA2 (0.54) GPR84FFAR1MAPTLCKPPARD
SCHEMBL8917383 0.90 GPR84 (0.61) GPR84FFAR1MAPTLCKPPARD
SCHEMBL5054302 0.90 GPR84 (0.61) GPR84FFAR1MAPTLCKPPARD
SCHEMBL11806278 0.90 GPR84 (0.61) GPR84FFAR1MAPTLCKPPARD
SCHEMBL21679674 0.90 GPR84 (0.61) GPR84FFAR1MAPTLCKPPARD
SCHEMBL21679654 0.90 GPR84 (0.61) GPR84FFAR1MAPTLCKPPARD
SCHEMBL159858 0.90 GPR84 (0.61) GPR84FFAR1MAPTLCKPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3681875-B1 CYCLIC PEPTIDE ANTIBIOTICS HOFFMANN LA ROCHE (CH) 2026-01-14 EP disclosed
CN-111148739-B Cyclic peptide antibiotics 豪夫迈·罗氏有限公司 2025-06-03 CN disclosed
US-11279735-B2 Cyclic peptide antibiotics GENENTECH, INC. (US) 2022-03-22 US disclosed
US-11279735-B2 Cyclic peptide antibiotics GENENTECH, INC. (US) 2022-03-22 US disclosed
US-20200331968-A1 CYCLIC PEPTIDE ANTIBIOTICS GENENTECH, INC. (US) 2020-10-22 US disclosed
US-20200331968-A1 CYCLIC PEPTIDE ANTIBIOTICS GENENTECH, INC. (US) 2020-10-22 US disclosed
CN-111148739-A Cyclopeptide antibiotics 豪夫迈·罗氏有限公司 2020-05-12 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200331968-A1 CYCLIC PEPTIDE ANTIBIOTICS NPPA, LNPEP, CLPP GPR84 2132/4885FFAR1 3214/4885MAPT 4597/4885
US-11279735-B2 Cyclic peptide antibiotics NPPA, LNPEP, CLPP GPR84 2132/4885FFAR1 3214/4885MAPT 4597/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.